VCAM1 and autoimmune myocarditis: The expression of VCAM-1 has been proposed as a biomarker in immunological diseases (experimental autoimmune myocarditis), as a predictor of mortality and morbidity in patients with chronic heart failure, and in those with endothelial injury in patients with coronary artery disease and arrhythmia.